CDBI Partners
CDBI Partners is a company.
Active
Updated: ·
Financial History
Total Raised
N/A
Valuation
N/A
Leadership Team
Key people at CDBI Partners.
CDBI Partners is a company.
Key people at CDBI Partners.
Key people at CDBI Partners.
CDBI Partners is a Shanghai-based private equity and venture capital firm specializing in growth equity and fund-of-funds investments in China, with a primary focus on Healthcare (including Biotech, HealthTech, Medical Devices) and Technology, Media & Telecommunications (TMT) sectors.[1][2] The firm has made 90 investments, achieved 12 portfolio exits (such as Aidite Technology's acquisition in June 2024), and manages 2 funds, contributing to China's startup ecosystem by backing high-growth companies in critical innovation areas like medical tech and digital transformation.[1] Its investment philosophy emphasizes scalable opportunities in these sectors, supporting ecosystem growth through capital infusion and strategic partnerships, as seen in co-investments with firms like Gaorong Capital and Legend Star.[1]
CDBI Partners operates from Room 1108, CITIC Pacific Plaza in Shanghai, China, with contact at +8621 62609156, but specific founding year and key partners are not detailed in available records.[1] The firm has evolved as a player in China's PE/VC landscape, focusing on growth-stage investments in healthcare and TMT, evidenced by its 90 investments and recent exits like Aidite Technology.[1] It has participated in notable funding rounds, such as angel investments in 2017-2018 and later backing for companies like SprintRay, highlighting its progression amid China's booming tech-health intersection.[1]
CDBI Partners rides China's healthcare-tech convergence trend, where aging demographics and digital innovation drive demand for Biotech, HealthTech, and Medical Devices amid post-pandemic recovery.[1][2] Timing aligns with government pushes for tech self-reliance and TMT expansion, positioning the firm to capitalize on market forces like rising VC inflows into Asia-Pacific innovation.[1] It influences the ecosystem by enabling exits (12 to date) and scaling startups, fostering a cycle of reinvestment in Shanghai's vibrant scene and bridging domestic growth with global co-investors.[1]
CDBI Partners is poised to expand in AI-health intersections and TMT amid China's 2025+ tech boom, potentially increasing exits and fund raises as portfolio matures. Trends like digital health scalability and cross-border syndicates will shape its path, evolving its influence from regional backer to key Asia-Pacific growth engine—building on its 90 investments to drive the next wave of Chinese unicorns.[1][2]
